Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Organon & Co. Director's Dealing 2025

May 7, 2025

31461_dirs_2025-05-07_9bc1ea0a-a25c-4124-8807-2985a959cd46.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2025-05-07

Reporting Person: Falcione Aaron (Chief Human Resources Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-07 Common Stock P 5500 $8.77 Acquired 62973.661 Direct